Senator Investment Group LP Legend Biotech Corp Transaction History
Senator Investment Group LP
- $2.03 Billion
- Q3 2024
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$409 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$275 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$243 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$210 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$185 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.13B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...